David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 9.51% |
| 3 | Healthcare | 7.52% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMED
951
DELISTED
Amedisys
AMED
| $14.8M | 0.02% |
152,777
-45,624
| -23% | -$5.44M |
|
952
Xenon Pharmaceuticals
XENE
$5.86B
| $14.8M | 0.02% |
409,563
+83,021
| +25% | +$2.98M |
|
|
SAMA
953
DELISTED
Schultze Special Purpose Acquisition Corp. II Class A Common Stock
SAMA
| $14.8M | 0.02% |
1,485,000
| – | – |
|
|
KRNL
954
DELISTED
Kernel Group Holdings, Inc. Class A Ordinary Shares
KRNL
| $14.8M | 0.02% |
1,487,583
+931,988
| +168% | +$9.21M |
|
|
HTPA
955
DELISTED
Highland Transcend Partners I Corp.
HTPA
| $14.7M | 0.02% |
1,479,227
+852,635
| +136% | +$8.46M |
|
|
TCOA
956
DELISTED
Zalatoris Acquisition Corp.
TCOA
| $14.7M | 0.02% |
1,485,000
| – | – |
|
|
AUY
957
DELISTED
Yamana Gold, Inc.
AUY
| $14.7M | 0.02% |
3,248,025
+3,180,261
| +4,693% | +$14.7M |
|
958
CALL
Scotiabank
BNS
$106B
| $14.7M | 0.02% |
309,600
+50,000
| +19% | +$2.86M |
|
959
CALL
American Airlines Group
AAL
$9.02B
| $14.7M | 0.02% |
1,220,800
-48,900
| -4% | -$682K |
|
960
CALL
Intuitive Surgical
ISRG
$132B
| $14.7M | 0.02% |
78,400
| – | – |
|
961
Manulife Financial
MFC
$71B
| $14.7M | 0.02% |
935,240
+396,300
| +74% | +$6.95M |
|
|
WRK
962
DELISTED
WestRock Company
WRK
| $14.6M | 0.02% |
473,707
+209,852
| +80% | +$8.29M |
|
963
CALL
Twilio
TWLO
$34.2B
| $14.6M | 0.02% |
211,600
-74,200
| -26% | -$5.93M |
|
|
PEGR
964
DELISTED
Project Energy Reimagined Acquisition Corp. Class A Ordinary Share
PEGR
| $14.6M | 0.02% |
1,485,000
| – | – |
|
|
DCPH
965
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $14.6M | 0.02% |
790,411
+623,526
| +374% | +$9.79M |
|
966
Evolent Health
EVH
$534M
| $14.6M | 0.02% |
406,944
-105,210
| -21% | -$3.71M |
|
967
PUT
Seagate
STX
$180B
| $14.6M | 0.02% |
274,300
+64,300
| +31% | +$4.65M |
|
968
NETSCOUT
NTCT
$2.75B
| $14.6M | 0.02% |
464,887
+26,683
| +6% | +$873K |
|
969
Manhattan Associates
MANH
$12.4B
| $14.5M | 0.02% |
109,007
-31,821
| -23% | -$4.31M |
|
970
PUT
Dell
DELL
$280B
| $14.5M | 0.02% |
423,900
+340,000
| +405% | +$14.3M |
|
|
ROSE
971
DELISTED
Rose Hill Acquisition Corporation Class A Ordinary Shares
ROSE
| $14.5M | 0.02% |
1,422,727
| – | – |
|
972
Estee Lauder
EL
$37.7B
| $14.4M | 0.02% |
66,872
+10,065
| +18% | +$2.57M |
|
973
Cameco
CCJ
$44.5B
| $14.4M | 0.02% |
542,364
+107,739
| +25% | +$2.76M |
|
974
iHeartMedia
IHRT
$415M
| $14.4M | 0.02% |
1,961,199
| – | – |
|
975
Constellium
CSTM
$3.61B
| $14.4M | 0.02% |
1,415,549
+119,867
| +9% | +$1.59M |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.